Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anti-Cancer Activity of Biotin-Polyoxomolybdate Bioconjugate Publisher



Hosseini MS1 ; Javanmard SH2 ; Rafiei L1 ; Hariri AA1 ; Dana N2 ; Rostami M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical sciences, Isfahan, Iran

Source: Eurasian Journal of Medicine and Oncology Published:2020


Abstract

Objectives: Polyoxometalates (POMs), polyanionic metal clusters, have been well recognized for their anticancer activity in recent decades. Despite their potential anticancer activity, normal cell toxicity is one of the pressing issues that prevent their further clinical applications. In this work, we synthesized a new bio-conjugate based on POM and biotin. We used biotin as a bio-molecule to control the cytotoxicity of POM on healthy cells and simultaneously increase the toxicity on cancerous cells. Methods: We synthesized the biotin derivative of POM via an amidation between the two molecules of biotin and amine groups on polyoxomolybdate. We approved the final structure using different spectroscopic data. We studied the cytotoxicity activity in-vitro using MTT protocol. We chose breast carcinoma cells (MCF-7) and hepatocellular carcinoma cells (HepG2) in comparison to the human umbilical vein endothelial cell (HUVEC). Results: Results showed that biotin could improve the anticancer activity of polyoxomoybdate (IC50; 0.082 mM) on MCF-7 and (IC50; 0.091 mM) on HepG2 cells. Furthermore, the biotin-polyoxomolybdate conjugate showed lower toxicity on healthy cells versus the parent polyoxomolybdate and the Cis-platin as an approved drug. Conclusion: Thus, we introduce promising novel POM bioconjugate, which can be further assessed in pre-clinical studies. © 2020 by Eurasian Journal of Medicine and Oncology.
Related Docs
View other Related Docs
1. Novel Tocopherol Succinate-Polyoxomolybdate Bioconjugate As Potential Anti-Cancer Agent, Journal of Inorganic and Organometallic Polymers and Materials (2021)
2. Eudesmic Acid-Polyoxomolybdate Organo-Conjugate As Novel Anticancer Agent, Journal of Molecular Structure (2021)
3. Biotin-Targeted Nanomicellar Formulation of an Anderson-Type Polyoxomolybdate: Synthesis and in Vitro Cytotoxicity Evaluations, Langmuir (2021)
4. Anderson-Type Manganese Polyoxomolybdate Hybrid Nanocomposite for Boosting Drug Delivery Against Breast Cancer, Journal of Drug Delivery Science and Technology (2023)
5. Co-Delivery of Arsenotungstate Polyoxometalate and Curcumin Using Bis-Imidazolium Poly Ionic Liquid Nanocomposites for Boosting Anticancer Effects Against Triple-Negative Breast Cancer Cells, Journal of Inorganic and Organometallic Polymers and Materials (2024)
6. Copper-Curcumin-Bipyridine Dicarboxylate Complexes As Anticancer Candidates, Chemistry and Biodiversity (2022)
7. Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles, Frontiers in Pharmacology (2022)
8. Quantum Mechanical/Molecular Mechanical and Docking Study of the Novel Analogues Based on Hybridization of Common Pharmacophores As Potential Anti-Breast Cancer Agents, Research in Pharmaceutical Sciences (2017)
Experts (# of related papers)
View all Related Experts
Mahboubeh Rostami (14)
Jaleh Varshosaz (10)
Other Related Docs
9. Hyaluronic Acid Targeted Metal Organic Framework Based on Iron (Iii) for Delivery of Platinum Curcumin Cytotoxic Agent to Triple Negative Breast Cancer Cell Line, Applied Organometallic Chemistry (2022)
10. Co-Delivery of Dasatinib and Mir-30A by Liposomes Targeting Neuropilin-1 Receptors for Triple-Negative Breast Cancer Therapy, Journal of Materials Chemistry B (2024)
11. Chitosan–Imidazolium Core–Shell Nanoparticles of Gd-Mn-Mo Polyoxometalate As Novel Potential Mri Nano-Agent for Breast Cancer Detection, Micromachines (2023)
12. Evaluation of Anticancer Effects of Cerium Oxide Nanoparticles on Mouse Fibrosarcoma Cell Line, Journal of Cellular Physiology (2019)
13. Design, Synthesis, and Comparison of Pla-Peg-Pla and Peg-Pla-Peg Copolymers for Curcumin Delivery to Cancer Cells, Polymers (2023)
14. Ph-Responsive Glucosamine Anchored Polydopamine Coated Mesoporous Silica Nanoparticles for Delivery of Anderson-Type Polyoxomolybdate in Breast Cancer, Journal of Microencapsulation (2022)
15. Myricetin Exerts Its Apoptotic Effects on Mcf-7 Breast Cancer Cells Through Evoking the Brca1-Gadd45 Pathway, Asian Pacific Journal of Cancer Prevention (2020)
16. Fluorescence Resonance Energy Transfer Monitoring of Ph-Responsive Doxorubicin Release From Carbon Dots/Aptamer Functionalized Magnetic Mesoporous Silica, Nanomedicine (2021)
17. Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments, Research in Pharmaceutical Sciences (2020)
18. Her-2 Aptamer-Targeted Ecoflex® Nanoparticles Loaded With Docetaxel Promote Breast Cancer Cells Apoptosis and Anti-Metastatic Effect, IET Nanobiotechnology (2019)
19. Assessment of Ph Responsive Delivery of Methotrexate Based on Phema-St-Peg-Da Nanohydrogels, Macromolecular Research (2021)
20. In Vitro Study of Sonodynamic Therapy Using Gemcitabine-Loaded Peg-Gold Nanoparticles Against Mcf-7 Breast Cancer Cells, BioNanoScience (2024)
21. The Art of Design in Azlactone-Benzoxazinone Chemistry, Docking Studies and in Vitro Cytotoxicity Evaluation, Australian Journal of Chemistry (2022)
22. The Cytotoxicity of 27-Hydroxycholesterol in Mcf-7 and Mda-Mb-231, Advanced Biomedical Research (2023)
23. Polyoxometalates As Next-Generation of Theragnostic Gadgets in Cancer, Reviews in Inorganic Chemistry (2024)
24. Natural Resources for Sustainable Synthesis of Nanomaterials With Anticancer Applications: A Move Toward Green Nanomedicine, Environmental Research (2023)
25. Exploring the Potential of Montmorillonite As an Antiproliferative Nanoagent Against Mda-Mb-231 and Mcf-7 Human Breast Cancer Cells, Cells (2024)
26. Anti-Tumor Effects of Ellagic Acid and Mesenchymal Stem Cell-Conditioned Medium on Breast Cancer Cells on the 3D Printed Pcl/Agarose Scaffolds, Journal of Drug Delivery Science and Technology (2024)
27. Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent, Journal of Nanomedicine and Nanotechnology (2012)
28. Mxenes in Cancer Nanotheranostics, Nanomaterials (2022)
29. Synthesis of Pectin-Deoxycholic Acid Conjugate for Targeted Delivery of Anticancer Drugs in Hepatocellular Carcinoma, International Journal of Biological Macromolecules (2019)
30. Redox Sensitive Polysaccharide Based Nanoparticles for Improved Cancer Treatment: A Comprehensive Review, Current Pharmaceutical Design (2018)
31. Evaluation of the Cytotoxic Effect of Hydroxypyridinone Derivatives on Hct116 and Sw480 Colon Cancer Cell Lines, Pharmaceutical Chemistry Journal (2019)
32. Copper(Ii) Complexes With Tridentate Halogen-Substituted Schiff Base Ligands: Synthesis, Crystal Structures and Investigating the Effect of Halogenation, Leaving Groups and Ligand Flexibility on Antiproliferative Activities, Dalton Transactions (2021)
33. Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment, Materials Science and Engineering C (2021)
34. A Bi-Functional Targeted P28-Nrc Chimeric Protein With Enhanced Cytotoxic Effects on Breast Cancer Cell Lines, Iranian Journal of Pharmaceutical Research (2019)
35. Methotrexate-Conjugated to Polymer Quantum Dot for Cytotoxicity Effect Improved Against Mcf-7 and Hela Cells, Medicinal Chemistry Research (2018)